GLP-1 is produced in the intestine in response to food intake. GLP-1 plays a crucial role in regulating blood sugar levels by stimulating the release of insulin from the pancreas and reducing the secretion of glucagon, a hormone that raises blood sugar levels.

The most common side effects include:

• Nausea

• diarrhea

• stomach

• vomiting

• constipation

This slows down the emptying of the stomach, leading to a feeling of fullness and reduced appetite. This effect can be particularly beneficial for individuals struggling with obesity or overweight, as it helps to control food intake and promote weight loss.

In addition to its effects on blood sugar control, GLP-1 RECEPTOR AGONIST has been shown to promote weight loss in patients with obesity. By reducing appetite and calorie intake, as well as increasing feelings of satiety, can help individuals achieve sustainable weight loss and improve their overall health.

One of the key advantages of this substance is its convenient once-weekly dosing regimen. This long-acting formulation provides continuous blood sugar control and appetite suppression throughout the week, offering patients greater flexibility and convenience in managing their condition.

By activating GLP-1 receptors in the body, this helps to lower blood sugar levels by increasing insulin secretion and decreasing glucagon release. This dual mechanism of action helps to normalize blood sugar levels, reducing the risk of hyperglycemia (high blood sugar) in patients with type 2 diabetes.

Clinical studies have demonstrated the efficacy and safety of GLP-1 Receptor Agonists in improving glycemic control and promoting weight loss in patients with type 2 diabetes and obesity. It has been shown to significantly reduce HbA1c levels (a measure of long-term blood sugar control) and achieve meaningful weight loss when used as part of a comprehensive treatment plan.